114 related articles for article (PubMed ID: 1763562)
1. [Effect of pellet size of a pancreas enzyme preparation on duodenal lipolytic activity].
Kühnelt P; Mundlos S; Adler G
Z Gastroenterol; 1991 Sep; 29(9):417-21. PubMed ID: 1763562
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
Dutta SK; Rubin J; Harvey J
Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
[TBL] [Abstract][Full Text] [Related]
3. New methods for assessment of enzyme activity: do they help to optimize enzyme treatment?
Adler G; Mundlos S; Kühnelt P; Dreyer E
Digestion; 1993; 54 Suppl 2():3-9. PubMed ID: 7693531
[TBL] [Abstract][Full Text] [Related]
4. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
Löhr JM; Hummel FM; Pirilis KT; Steinkamp G; Körner A; Henniges F
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1024-31. PubMed ID: 19352190
[TBL] [Abstract][Full Text] [Related]
5. Optimal size range for enteric-coated pancreatin preparations.
Lederer PC
Pancreas; 2011 Mar; 40(2):310-1. PubMed ID: 21311309
[No Abstract] [Full Text] [Related]
6. In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability.
Aloulou A; Puccinelli D; Sarles J; Laugier R; Leblond Y; Carrière F
Aliment Pharmacol Ther; 2008 Feb; 27(3):283-92. PubMed ID: 17973644
[TBL] [Abstract][Full Text] [Related]
7. Monitoring enzyme replacement treatment in exocrine pancreatic insufficiency using the cholesteryl octanoate breath test.
Mundlos S; Kühnelt P; Adler G
Gut; 1990 Nov; 31(11):1324-8. PubMed ID: 2253920
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
Löser C; Fölsch UR
Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of enteric-coated pancreatin microsphere therapy after conventional and pylorus-preserving pancreatoduodenectomy.
Bruno MJ; Borm JJ; Hoek FJ; Delzenne B; Hofmann AF; de Goeij JJ; van Royen EA; van Gulik TM; de Wit LT; Gouma DJ; van Leeuwen DJ; Tytgat GN
Br J Surg; 1997 Jul; 84(7):952-6. PubMed ID: 9240133
[TBL] [Abstract][Full Text] [Related]
10. Effects of pectin and wheat bran on intraluminal pancreatic enzyme activities and on fat absorption as examined with the triolein breath test in patients with pancreatic insufficiency.
Isaksson G; Lundquist I; Akesson B; Ihse I
Scand J Gastroenterol; 1984 Jun; 19(4):467-72. PubMed ID: 6205439
[TBL] [Abstract][Full Text] [Related]
11. Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin.
Neoptolemos JP; Ghaneh P; Andrén-Sandberg A; Bramhall S; Patankar R; Kleibeuker JH; Johnson CD
Int J Pancreatol; 1999 Jun; 25(3):171-80. PubMed ID: 10453419
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, randomized, multicentre, crossover study to prove equivalence of pancreatin minimicrospheres versus microspheres in exocrine pancreatic insufficiency.
Halm U; Löser C; Löhr M; Katschinski M; Mössner J
Aliment Pharmacol Ther; 1999 Jul; 13(7):951-7. PubMed ID: 10383531
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic enzyme replacement therapy: comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis.
Schneider MU; Knoll-Ruzicka ML; Domschke S; Heptner G; Domschke W
Hepatogastroenterology; 1985 Apr; 32(2):97-102. PubMed ID: 2408983
[TBL] [Abstract][Full Text] [Related]
14. Does the pancreas really produce much more lipase than required for fat digestion?
Carrière F; Grandval P; Gregory PC; Renou C; Henniges F; Sander-Struckmeier S; Laugier R
JOP; 2005 May; 6(3):206-15. PubMed ID: 15883471
[TBL] [Abstract][Full Text] [Related]
15. Gastric transit and pharmacodynamics of a two-millimeter enteric-coated pancreatin microsphere preparation in patients with chronic pancreatitis.
Bruno MJ; Borm JJ; Hoek FJ; Delzenne B; Hofmann AF; de Goeij JJ; van Royen EA; van Leeuwen DJ; Tytgat GN
Dig Dis Sci; 1998 Jan; 43(1):203-13. PubMed ID: 9508526
[TBL] [Abstract][Full Text] [Related]
16. Fate of oral enzymes in pancreatic insufficiency.
Guarner L; Rodríguez R; Guarner F; Malagelada JR
Gut; 1993 May; 34(5):708-12. PubMed ID: 8504976
[TBL] [Abstract][Full Text] [Related]
17. [Dose-dependent effect of pancreatin replacement upon the pancreatic function in the period after pancreatic surgery].
Farkas G; Leindler L; Mihalovits G
Magy Seb; 2001 Dec; 54(6):347-50. PubMed ID: 11816130
[TBL] [Abstract][Full Text] [Related]
18. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage?
Lankisch PG; Lembcke B; Göke B; Creutzfeldt W
Z Gastroenterol; 1986 Dec; 24(12):753-7. PubMed ID: 3548109
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
Ansaldi-Balocco N; Santini B; Sarchi C
J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
[TBL] [Abstract][Full Text] [Related]
20. Role of nonpancreatic lipolytic activity in exocrine pancreatic insufficiency.
Abrams CK; Hamosh M; Dutta SK; Hubbard VS; Hamosh P
Gastroenterology; 1987 Jan; 92(1):125-9. PubMed ID: 3781179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
